Celecoxib Combined with Diacerein Effectively Alleviates Osteoarthritis in Rats via Regulating JNK and p38MAPK Signaling Pathways
- 18 February 2015
- journal article
- Published by Springer Nature in Inflammation
- Vol. 38 (4) , 1563-1572
Abstract
Osteoarthritis (OA) has long been a difficult to overcome joint disease for medical workers. However, there is still a lack of effective treatments for OA. In the present study, we aimed to evaluate the treatment effect of celecoxib (CLX) combined with diacerein (DC) on OA and delineate the underlying molecular mechanism. The OA model was established by using rats, and OA rats were treated with either CLX alone, DC alone, and CLX combined with DC. The results showed that, as compared with a single treatment of CLX or DC, CLX combined with DC markedly attenuated OA and inhibited the levels of inflammatory mediators interleukin-1β and nitric oxide, improved bone cartilage metabolism, and suppressed chondrocyte apoptosis. Most importantly, CLX combined with DC significantly inactivated the c-Jun N-terminal kinases (JNK) signaling pathway by the inhibition of MEKK1 and MKK7, as detected by Western blot analysis. Furthermore, the protein expression of downstream genes of JNK, including activating-transcription factor (Atf-2), matrix metalloproteinase-13 (MMP-13), and cyclooxygenase (COX-2), were also significantly inhibited by CLX combined with DC as compared with single treatments. Furthermore, CLX combined with DC also effectively inhibits p38 mitogen-activated protein kinase and nuclear factor-κB signaling pathways. Taken together, our study suggests that CLX combined with DC has satisfactory treatment effects on OA via a stronger inhibitory effect on inflammatory signaling pathway.Keywords
This publication has 37 references indexed in Scilit:
- TNF/TNFR signal transduction pathway-mediated anti-apoptosis and anti-inflammatory effects of sodium ferulate on IL-1β-induced rat osteoarthritis chondrocytes in vitroArthritis Research & Therapy, 2012
- Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritisArthritis Research & Therapy, 2011
- Effects of diacerein at the molecular level in the osteoarthritis disease processTherapeutic Advances in Musculoskeletal Disease, 2010
- JNK signaling in apoptosisOncogene, 2008
- Diacerein inhibits the synthesis of resorptive enzymes and reduces osteoclastic differentiation/survival in osteoarthritic subchondral bone: a possible mechanism for a protective effect against subchondral bone remodellingArthritis Research & Therapy, 2008
- Nitric Oxide and Peroxynitrite in Health and DiseasePhysiological Reviews, 2007
- Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skinCarcinogenesis, 2003
- The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritisArthritis & Rheumatism, 2000
- Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3Arthritis & Rheumatism, 2000
- Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritisOsteoarthritis and Cartilage, 1996